Brief: Biocartis Group NV - Biocartis And Skylinedx Sign Collaboration To Develop Merlin Assay Test

Biocartis NV

22/04/2021 06:10

April 22 (Reuters) - Biocartis Group NV  BCART.BR :
    * BIOCARTIS GROUP NV - BIOCARTIS AND SKYLINEDX SIGN
COLLABORATION
TO DEVELOP MERLIN ASSAY, A TEST PREDICTING RISK FOR NODAL
METASTASIS IN MELANOMA, ON IDYLLA™
    * BIOCARTIS GROUP NV - INITIATION OF DEVELOPMENT OF MERLIN
ASSAY
ON IDYLLA™ IS EXPECTED TO START IN 2021.
    * BIOCARTIS GROUP NV - BIOCARTIS WILL INVEST UP TO EUR 10M
IN
SECURED CONVERTIBLE NOTES TO BE ISSUED BY SKYLINEDX IN DIFFERENT
PROJECT-BASED INSTALMENTS THROUGHOUT COLLABORATION

Source text for Eikon:  ID:nGNE4n5Df6 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))